IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals

Several studies have shown physiological functions of interleukin (IL)-32, a novel cytokine. However, the role of IL-32 in cancer development has not been reported. In this study, we showed that IL-32γ inhibited tumor growth in IL-32γ-overexpressing transgenic mice inoculated with melanoma as well a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Oh, J H, Cho, M-C, Kim, J-H, Lee, S Y, Kim, H J, Park, E S, Ban, J O, Kang, J-W, Lee, D-H, Shim, J-H, Han, S B, Moon, D C, Park, Y H, Yu, D-Y, Kim, J-M, Kim, S H, Yoon, D-Y, Hong, J T
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2011
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3145890/
https://ncbi.nlm.nih.gov/pubmed/21423208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.52
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires